Clinical data
| Patient ID | HLA Type | Stagea | Adjuvant | Vaccine- Induced CD8+ T Cell Responseb | Progression- Free at 1 Year |
|---|---|---|---|---|---|
| 445 | A*0201 | II | IL-2 lipc | − | Yes |
| 475 | A*0201 | IV | Alumd | − | Yes |
| 443 | A*0201 | III | Alum | − | No |
| 471 | A*0201 | IV | IL-2 lip | − | No |
| 462 | A*0201 | III | IL-2 lip | − | No |
| 477 | A*0201 | II | IL-2 lip | − | No |
| 483 | A*0201 | III | IL-2 lip | − | No |
| 484 | A*0205 | II | IL-2 lip | − | No |
| 465 | A*0201 | IV | Alum | − | No |
| 436 | A*0201 | III | IL-2 lip | + | Yes |
| 191 | A*0201 | III | IL-2 lip | + | Yes |
| 375 | A*0201 | III | IL-2 lip | + | Yes |
| 422 | A*0201 | III | IL-2 lip | + | Yes |
| 442 | A*0201 | IV | IL-2 lip | + | Yes |
| 460 | A*0201 | II | IL-2 lip | + | Yes |
| 468 | A*0201 | II | IL-2 lip | + | Yes |
| 458 | A*0201 | III | Alum | + | No |
| 418 | A*0201 | IV | IL-2 lip | + | No |
| 482 | A*0201 | IV | IL-2 lip | + | No |
| 467 | A*0201 | III | IL-2 lip | + | No |
| 478 | A*0201 | II | IL-2 lip | + | No |
| 479 | A*0201 | II | IL-2 lip | + | No |
a AJCC stage diagnosis at time of first vaccine immunization.
b Vaccine-induced CD8+ T cell response to one or more of the studied Ags.
c Vaccine was encapsulated in liposomes along with IL-2.
d Vaccine was bound to alum.